These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25145915)

  • 1. Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.
    Schütz C; Fleck M; Schneck JP; Oelke M
    J Vis Exp; 2014 Aug; (90):e51859. PubMed ID: 25145915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
    Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
    Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
    Schütz C; Fleck M; Mackensen A; Zoso A; Halbritter D; Schneck JP; Oelke M
    Blood; 2008 Apr; 111(7):3546-52. PubMed ID: 18096763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.
    Schütz C; Oelke M; Schneck JP; Mackensen A; Fleck M
    Immunotherapy; 2010 Jul; 2(4):539-50. PubMed ID: 20636007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells.
    Kosiewicz MM; Alard P
    Immunol Res; 2004; 30(2):155-70. PubMed ID: 15477657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
    Dupont J; Latouche JB; Ma C; Sadelain M
    Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
    Shepard ER; Wegner A; Hill EV; Burton BR; Aerts S; Schurgers E; Hoedemaekers B; Ng STH; Streeter HB; Jansson L; Wraith DC
    Front Immunol; 2021; 12():654201. PubMed ID: 33936079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
    Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
    Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological advances in adoptive immunotherapy.
    Oelke M; Krueger C; Schneck JP
    Drugs Today (Barc); 2005 Jan; 41(1):13-21. PubMed ID: 15753966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
    Shao J; Xu Q; Su S; Wei J; Meng F; Chen F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Dec; 334():78-86. PubMed ID: 30392890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
    Schultze JL; Michalak S; Seamon MJ; Dranoff G; Jung K; Daley J; Delgado JC; Gribben JG; Nadler LM
    J Clin Invest; 1997 Dec; 100(11):2757-65. PubMed ID: 9389740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-Class II Artificial Antigen Presenting Cells in CD4
    Couture A; Garnier A; Docagne F; Boyer O; Vivien D; Le-Mauff B; Latouche JB; Toutirais O
    Front Immunol; 2019; 10():1081. PubMed ID: 31156634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators.
    Phillips WJ; Smith DJ; Bona CA; Bot A; Zaghouani H
    Int Rev Immunol; 2005; 24(5-6):501-17. PubMed ID: 16318992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.
    Hammer MH; Meyer S; Brestrich G; Moosmann A; Kern F; Tesfa L; Babel N; Mittenzweig A; Rooney CM; Hammerschmidt W; Volk HD; Reinke P
    Eur J Immunol; 2005 Jul; 35(7):2250-8. PubMed ID: 15915543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cell-based artificial antigen-presenting cells for cancer immunotherapy.
    Butler MO; Hirano N
    Immunol Rev; 2014 Jan; 257(1):191-209. PubMed ID: 24329798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial antigen-presenting cells: artificial solutions for real diseases.
    Oelke M; Krueger C; Giuntoli RL; Schneck JP
    Trends Mol Med; 2005 Sep; 11(9):412-20. PubMed ID: 16103011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tumor surveillance after adoptive T-cell therapy.
    Matter M; Pavelic V; Pinschewer DD; Mumprecht S; Eschli B; Giroglou T; von Laer D; Ochsenbein AF
    Cancer Res; 2007 Aug; 67(15):7467-76. PubMed ID: 17671217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.